Aastrom Biosciences, Inc. to Host Third Quarter 2011 Investor Call on Tuesday, November 8, 2011

ANN ARBOR, Mich., Oct. 31, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, announces the following webcast:
MORE ON THIS TOPIC